PHARMA LAB · PL-02-013
Culture media: preparation, sterilisation and storage

In this article
A culture medium must reach the test with known identity, status and performance. Its journey includes purchasing, any local preparation, processing, dispensing and storage. A problem at one stage may emerge only when the microbiological result is interpreted.
Effective control connects each container to its lot and each decision to relevant data. This article focuses on material management; verification of its functions is covered in growth promotion testing and other performance checks.
1. Choose the format and assign responsibilities
Ready-to-use media reduce local operations but require purchasing requirements, a qualified supplier and receipt checks. A dehydrated formulation transfers preparation and processing responsibilities to the laboratory. Preparation from individual components also requires a controlled formula and traceability of every ingredient.
Define intended use, specification, final format and required documentation before ordering. Clarify who reviews certificates, prepares the medium, performs checks and authorises use. An unchanged commercial code alone does not demonstrate that supply and conditions remain identical.
2. Check receipt, water and materials
Compare identity, lot, expiry, packaging and documents against the approved order. Assess integrity and transport conditions; a label statement does not replace required checks. Keep materials awaiting acceptance identified and prevent accidental selection.
WHO good practices, 2011, section 5.2, address microbiologically appropriate water without interfering substances, suitable storage and control of deteriorated materials. Translate these principles into checks linked to the water actually used, containers and utensil cleaning. Detergent residues or inhibitory components can alter the test without changing the medium's name.
3. Control preparation, not just the formula
Use approved formulae and instructions for exact quantities, sequence and conditions. Record actual values, material lots, equipment, operator and relevant stages as they occur. A completed tick box does not make preparation reconstructable when required weights, volumes or adjustments are missing.
Define when pH and other characteristics are measured, by which method and against which specification. Retain measurement conditions and authorised corrections: a context-free value may not be comparable with the previous lot's result. Avoid improvised adjustments intended to bring an altered material back within limits.
4. Make processing compatible with performance
Sterilisation must suit the material and actual configuration. Formulation, volume, container, closure and load arrangement may influence processing. The selected programme alone does not describe what the medium experienced; evidence relevant to the load and cycle data are needed.
WHO distinguishes verification of autoclave configurations from medium quality. Heating and cooling phases may also matter. USP 1229, 2025 preview, points to specific chapters for different sterilisation modes: no single cycle transfers to every formulation.
An experimental study published in 2017 linked treatment of medium components to inhibitory substances and changes in recovery of freshwater microorganisms. It illustrates why processing may alter performance; it is neither a recipe nor a result that can be generalised to pharmaceutical media.
5. Dispense, identify and control status
Post-treatment dispensing must protect the material against recontamination under the specified conditions. Keep each pack linked to its lot, including after subdivision or transfer. Labels and records must establish identity, preparation, storage, expiry and status; a coloured sticker alone is insufficient if the decision is undocumented.
| Stage | Records to connect | Review question |
|---|---|---|
| Material | Identity, lots, receipt and documents | Were the accepted materials actually used? |
| Preparation | Formula/version, quantities, water, equipment and operator | Can preparation be reconstructed? |
| Processing | Configuration, load, cycle and anomalies | Does the process cover this configuration? |
| Checks | Original results, specification, deviations and decision | Do all required checks support use? |
| Storage | Location, conditions, duration and transfers | Do the conditions remain supported by evidence? |
| Use | Container, date, operator and associated test | Which results depend on this lot? |
For a rejected lot or one under investigation, make the block effective both in the records system and at the storage location. Physical availability must not be interpreted as permission to use it.
6. Distinguish shelf life from stage-specific holding times
Shelf life describes the period of suitability under defined conditions; a holding time concerns a specific stage, such as a wait between operations. They are not interchangeable. The powder's expiry does not automatically become the prepared medium's expiry, and opening a container does not reset elapsed time.
For prepared media, establish and verify duration and conditions with relevant evidence, as WHO requires. Consider packaging, water loss, light exposure, excursions and internal transport as appropriate to the material. Avoid unjustified conventional expiry periods. If conditions move outside the studied state, block and assess the impact before extending or confirming use.
7. Assess changes and deviations before claiming equivalence
Simulated case. To reduce handling, a laboratory moves to larger bottles and a more densely packed load while retaining the same programme. Chamber records look normal. This does not show that the medium received equivalent treatment or retained its required characteristics.
The team assesses container, volume and load against the qualified configuration, plans the necessary checks and tests final-lot performance. GPT does not replace evidence of treatment; a compliant cycle does not replace GPT. Use is authorised only on the required evidence package. If the change has already been implemented, affected lots and tests are traced.
Closing checklist: identified materials and formula; complete preparation data; covered configuration; acceptable checks; justified storage and duration; evaluated deviations; traceable decision and uses. Apply the same reasoning to changes in water, supplier, formulation or packaging.
Sources and consultation limits
- WHO, TRS 961, Annex 2, 2011: public full text, sections 4.3.5, 5.2 and 5.3.
- USP 1117, 2022 record and USP 1229, 2025 record: public scope previews; verify details and the method in the effective edition through authorised access.
- Study on peroxide formation and microbial recovery, 2017: public primary abstract, non-pharmaceutical experimental context.
Continue exploring
PL-02-015
Microbiological sample incubation: conditions, timing and excursions
A compliant setpoint does not tell the whole sample history. Reconstruct timing, transfers and conditions to assess deviations using relevant evidence.
Read the articlePL-02-014
Reference strains: traceability and laboratory management
A name on a container does not establish the reference’s complete history. Connect starting material, working references and tests to assess identity, suitability and the impact of gaps.
Read the articlePL-02-012
Growth promotion testing: media performance and result management
A sterile medium does not necessarily support the expected growth. Link properties, controls and evidence to intended use, and investigate failures without testing into compliance.
Read the article


